Skip to Main Content

CAMBRIDGE, Mass. — An explosion of biological data will lead to the first drug candidates discovered by an artificial intelligence system within the next few years, a feat that promises to change the way pharmaceutical companies conduct research.

That was a consensus opinion that emerged among experts in machine learning who spoke at the STAT Summit Thursday about the use of AI in the pharmaceutical industry.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED